NCT05168215View on ClinicalTrials.gov

Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

June 1, 2024

Study Completion Date

June 1, 2024

Conditions
SclerodermaDigital UlcerAutoimmune DiseasesDiffuse Cutaneous Systemic SclerosisReynold Syndrome
Trial Locations (1)

Unknown

RECRUITING

Laikon Hospital of Athens, Athens

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY